Floatz logo

Therapeutic Asset Ratings

13,157 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Docetaxel
Adenosquamous Lung Carcinoma
Wake Forest University Health SciencesP2B (62)
Docetaxel
Cholangiocarcinoma
Merck Sharp & Dohme LLCP2B (62)
Docetaxel
Sarcoma
IGM Biosciences, Inc.P2B (62)
DOXORUBICIN
Liver And Intrahepatic Bile Duct Neoplasm
Children's National Research InstituteP2B (62)
Durvalumab
Nonpapillary Renal Cell Carcinoma
AstraZenecaP2B (62)
DYNAMOS
Malignant Pancreatic Neoplasm
State University of New York - Downstate Medical CenterP2B (62)
Elacestrant
Breast Tumor Luminal A Or B
GBG Forschungs GmbHP2B (62)
Fludarabine
Chediak-Higashi Syndrome
Washington University School of MedicineP2B (62)
Fludarabine
Therapy-Related Myeloid Neoplasm
National Cancer Institute (NCI)P2B (62)
Fludarabine
HIV Infectious Disease
AIDS Malignancy ConsortiumP2B (62)
Fludarabine
Melanoma
Beijing BiotechP2B (62)
Fludarabine
Meningioma
Essen BiotechP2B (62)
Fludarabine
Neuroblastoma
Robbie MajznerP2B (62)
Fludarabine
Hairy Cell Leukemia
Kite, A Gilead CompanyP2B (62)
Fludarabine
Richter Transformation
Ohio State University Comprehensive Cancer CenterP2B (62)
Fludarabine
Renal Cell Carcinoma
Canadian Cancer Trials GroupP2B (62)
Fludarabine
Thymic Carcinoma
Beijing BiotechP2B (62)
FLUDEOXYGLUCOSE
Breast Cancer
Peking University Cancer Hospital & InstituteP2B (62)
FLUOROURACILUM
Biliary Tract Cancer
Shenzhen Xinhe BiomedicalP2B (62)
FLUOROURACILUM
Urinary Bladder Carcinoma
Arcus Biosciences, Inc.P2B (62)
FLUOROURACILUM
Ovarian Cancer
Lipomedix Pharmaceuticals Inc.P2B (62)
Glibenclamide
Traumatic Brain Injury
Beijing Tiantan HospitalP2B (62)
Golcadomide
Non-Hodgkin Lymphoma
University of PittsburghP2B (62)
htd1801
Metabolic Dysfunction-Associated Steatohepatitis
HighTide Biopharma Pty LtdP2B (62)
Humax-Cd20
Burkitt Lymphoma
M.D. Anderson Cancer CenterP2B (62)
Showing 1176 to 1200 of 13,157 assets
PreviousPage 48 of 527Next